What are the stages of pharmaceutical development?
The broad drug-development lifecycle typically progresses through discovery, preclinical research, pharmaceutical and formulation development, clinical trials, regulatory review, manufacturing scale-up, and post-market monitoring. These activities often overlap rather than occurring as completely separate sequential stages.
Answer
There is no single universal stage count for pharmaceutical development, but the broader drug-development lifecycle can be organized into several major phases.
1. Drug discovery
Researchers identify biological targets and investigate compounds or other therapeutic candidates that may have useful pharmacological activity.
2. Preclinical research
Laboratory and nonclinical studies generate information about pharmacology, toxicology, and other characteristics needed before appropriate human studies can begin.
3. Pharmaceutical and formulation development
The drug substance is developed into a suitable dosage form. Activities may include formulation design, excipient selection, analytical-method development, stability studies, manufacturing-process development, and production of clinical-trial material.
Importantly, pharmaceutical development and manufacturing-process development normally begin before regulatory approval and continue alongside clinical development.
4. Clinical development
Clinical trials evaluate the investigational medicine in people. Drug programs generally progress from early clinical studies through larger confirmatory trials as evidence is generated on safety, dosing, and therapeutic benefit.
5. Regulatory submission and review
The sponsor submits the required quality, nonclinical, and clinical evidence to the relevant regulatory authority for review. Manufacturing and Chemistry, Manufacturing and Controls (CMC) information forms part of this regulatory package.
6. Manufacturing scale-up and commercialization
Processes developed earlier are transferred or scaled for routine commercial production. Manufacturers establish validated or appropriately controlled production processes, quality systems, specifications, and supply arrangements.
7. Post-market monitoring and lifecycle management
Once a medicine is authorized and marketed, safety monitoring continues. Manufacturers and marketing authorization holders may also implement post-approval manufacturing changes, additional studies, or other lifecycle-management activities.
These stages are interconnected. Formulation development, analytical work, regulatory planning, manufacturing development, and quality activities can continue across several phases rather than occurring only once.
Trust Our Expert Answers?